Milinette 20/75 is a monophasic 21-day contraceptive pill containing the active ingredients ethinylestradiol and gestodene. It helps to make it harder for the sperm to penetrate the womb and to reduce the chance of a fertilised egg implanting in the womb. It is over 99% effective at preventing pregnancy if taken correctly.
Milinette 20/75 is a prescription only medicine, like any other prescription medication you must consult a doctor before using it.
Private Doc offers a confidential free consultation service that may result in you receiving a prescription for Milinette 20/75 if it is deemed appropriate and can prescribed safely.
Complete a 100% free and secure consultation to explore your treatment options.
Who can take Milinette 20/75
Private Doc will prescribe a 3-month supply of Milinette 20/75 contraceptive pill to women where Milinette 20/75 is suitable. Women qualify for Milinette 20/75 if:
- They have been taking Milinette 20/75 for the last year.
- They have had no problems with Milinette 20/75 in the last year.
They have had a face-to-face pill check-up for their contraceptive pill in the last year.
How to take Milinette 20/75
Take Milinette 20/75 every day for 21 days
- Milinette 20/75 comes in strips of 21 pills, each marked with a day of the week.
- Take your pill at the same time every day.
- Start by taking a pill marked with the correct day of the week.
- Follow the direction of the arrows on the strip. Take one pill each day, until you have finished all 21 pills
- Then have a 7-day break when you will have your period.
- Following the 7-day pill-free period start your new pack of pills on the 8th day.
Note - Swallow each pill whole, with water if necessary.
Do not take Milinette 20/75 if you have, or have had:
- Presence or risk of venous thromboembolism (VTE)
- Venous thromboembolism – current VTE (on anticoagulants) or history of (e.g. deep venous thrombosis [DVT] or pulmonary embolism [PE]).
- A Known hereditary or acquired predisposition for venous thromboembolism, such as APC-resistance, (including Factor V Leiden), antithrombin-III-deficiency, protein C deficiency, protein S deficiency.
- Major surgery with prolonged immobilisation
- A high risk of venous thromboembolism due to the presence of multiple risk factors.
- Presence or risk of arterial thromboembolism (ATE)
- Arterial thromboembolism – current arterial thromboembolism, history of arterial thromboembolism (e.g. myocardial infarction) or prodromal condition (e.g. angina pectoris).
- Cerebrovascular disease – current stroke, history of stroke or prodromal condition (e.g. transient ischaemic attack, TIA).
- Known hereditary or acquired predisposition for arterial thromboembolism, such as hyperhomocysteinaemia and antiphospholipid-antibodies (anticardiolipin-antibodies, lupus anticoagulant).
- History of migraine with focal neurological symptoms.
- A high risk of arterial thromboembolism due to multiple risk factors, or to the presence of one serious risk factor such as:
- Diabetes mellitus with vascular symptoms
- Severe hypertension
- Severe dyslipoproteinaemia.
- Pancreatitis or a history thereof if associated with severe hypertriglyceridemia
- Presence or history of severe hepatic disease as long as liver function values have not returned to normal.
- Presence or history of liver tumours (benign or malignant).
- Known or suspected sex steroid-influenced malignancies (e.g. of the genital organs or the breasts)
- Endometrial hyperplasia
- Undiagnosed vaginal bleeding.
- Known or suspected pregnancy.
- Allergy to the active ingredients
Patient Information Leaflet enclosed with your medicines for a full list of medicines that may affect your contraceptive pill.